Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
According to TheFly, Citi lowered its price target to $500 from $590 and keeps a ‘Buy’ rating.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the top high-conviction stocks to buy according to hedge funds. Deutsche Bank cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 on June 2 while maintaining a Sell rating on the shares. The stock also received a rating update from BofA on May 12, […]
ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.
Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On May 27, 2026, Goldman Sachs lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $558 from $621 and maintained a Buy rating on the shares. Goldman Sachs said MedTech has gone through one of its […]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical technology stocks to buy right now. On May 21, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced a major round of updates to its da Vinci 5 robotic surgical system, including extended instrument use capabilities. The company said more than 100 improvements will roll out to US customers […]
Intuitive Surgical (NasdaqGS:ISRG) has outlined more than 100 new features coming to its da Vinci 5 surgical platform. Key additions include extended-use Force Feedback instruments, security and reliability upgrades, and telepresence tools for remote collaboration. The company expects these updates to broaden the platform’s capabilities in minimally invasive robotic surgery and support surgeon autonomy. For investors watching NasdaqGS:ISRG at a share price of $439.8, this product update...